References
- Walia S, Alster TS. Prolonged clinical and histologic effects from CO2 laser resurfacing of atrophic acne scars. Dermatol Surg. 1999;25:926–30.
- Nanni CA, Alster TS. Complications of carbon dioxide laser resurfacing. An evaluation of 500 patients. Dermatol Surg. 1998;24:315–20.
- Hantash BM, Bedi VP, Chan KF, Zachary CB. Ex vivo histological characterization of a novel ablative fractional resurfacing device. Lasers Surg Med. 2007;39:87–95.
- Hantash BM, Bedi VP, Kapadia B, Rahman Z, Jiang K, Tanner H, . In vivo histological evaluation of a novel ablative fractional resurfacing device. Lasers Surg Med. 2007;39:96–107.
- Brightman L, Goldman MP, Taub AF. Sublative rejuvenation: experience with a new fractional radiofrequency system for skin rejuvenation and repair. J Drugs Dermatol. 2009;8:s9–13.
- Tanzi EL, Alster TS. Single-pass carbon dioxide versus multiple-pass Er:YAG laser skin resurfacing: a comparison of postoperative wound healing and side-effect rates. Dermatol Surg. 2003;29:80–4.
- Chapas AM, Brightman L, Sukal S, Hale E, Daniel D, Bernstein LJ, . Successful treatment of cuneiform scarring with CO2 ablative fractional resurfacing. Lasers Surg Med. 2008;40:381–6.
- Walgrave SE, Ortiz AE, MacFalls HT, Elkeeb L, Truitt AK, Tournas JA, . Evaluation of a novel fractional resurfacing device for treatment of acne scarring. Lasers Surg Med. 2009;41:122–7.
- Ortiz AE, Tremaine AM, Zachary CB. Long-term efficacy of a fractional resurfacing device. Lasers Surg Med. 2010;42: 168–70.